Quotient Limited Announces Estimated Third Quarter Fiscal 2016 Financial Results
Feb 03, 2016 21:01 pm UTC| Business
JERSEY, Channel Islands, Feb. 03, 2016 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced estimated financial results for its fiscal third quarter ended on December 31, 2015....
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
Feb 03, 2016 21:01 pm UTC| Business
JERSEY, Channel Islands, Feb. 03, 2016 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of $40 million of its...
Brooks Automation Reports Fiscal First Quarter of 2016 Ended December 31, 2015 Results
Feb 03, 2016 21:01 pm UTC| Business
CHELMSFORD, Mass., Feb. 03, 2016 -- Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences,...
Feb 03, 2016 21:01 pm UTC| Business
LOS ANGELES, Feb. 03, 2016 -- Hanmi Financial Corporation (NASDAQ:HAFC) (“Hanmi”), the holding company for Hanmi Bank (the “Bank”), today announced that Harry Chung and Michael Yang were appointed to its Board of...
Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger
Feb 03, 2016 21:01 pm UTC| Business
IRVINE, Calif., Feb. 03, 2016 -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has successfully completed the previously announced merger...
Amicus Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Feb 03, 2016 21:01 pm UTC| Business
CRANBURY, N.J., Feb. 03, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief Executive Officer, will...
Feb 03, 2016 21:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 03, 2016 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the company is scheduled to present at the...